The StraightFrom® Leukopak® REAlease® MicroBead Kit was developed for the rapid positive isolation of CD56+ cells directly from Leukopak® using the MultiMACS Cell 24 Separator Plus for semi-automated separation. No sample preparation is required, including density gradient centrifugation, erythrocyte lysis, or cell count. The Multi-24 Column Block is included in the kit to allow direct processsing of a 1/2 Leukopak®.
Related products for StraightFrom® Leukopak® REAlease® CD56 MicroBead Kit, human
The StraightFrom® Leukopak® REAlease® MicroBead Kit was developed for the rapid positive isolation of CD56+ cells directly from Leukopak® using the MultiMACS Cell 24 Separator Plus for semi-automated separation. No sample preparation is required, including density gradient centrifugation, erythrocyte lysis, or cell count. The Multi-24 Column Block is included in the kit to allow direct processsing of a 1/2 Leukopak®.
A Leukopak® sample is labeled with StraightFrom® Leukopak® REAlease® CD56 Biotin Complex followed by Anti-Biotin MicoBeads and loaded onto Multi-24 Column Block, which is placed in the magnetic field of a MultiMACS™ Cell24 Separator Plus. After removing the Multi-24 Column Block from the magnetic field, the magnetically retained CD56+ cells are eluted as the positively selected cell fraction bead-free, or free of MicroBeads. Optionally, the REAlease Biotin Complex can be removed for label-free target cells.
CD56+ cells isolated using StraightFrom® Leukopak® REAlease® CD56 MicroBeads are ideally suited for further magnetic separation, i.e. for the depletion of CD56+CD3+ cells with CD3 MicroBeads. The cells are suited for further flow cytometric analyses, molecular biology applications and functional studies.
Multi-24 Column Block
Step-by-step separation procedure
A) CD56+ cells were isolated from ½ Leukopak® using the StraightFrom® Leukopak® REAlease® CD56 MicroBead Kit, CD3 MicroBeads, Multi-24 Column Block, LD Columns for CD3 depletion, and a MultiMACS™ Cell24 Separator Plus. Cells were fluorescently stained with REAfinity® Antibodies CD56-APC, CD3-FITC, and Biotin Antibody-PE and analyzed by flow cytometry using the MACSQuant® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.
B) The efficient removal of all labels was shown by using Biotin Antibody-PE to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD56+ cells”), whereas the label-free CD56+ cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation.